Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 21, 2018
UroGen Pharma Announces Positive Interim Results from Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)
RA’ANANA, Israel and NEW YORK, May 21, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
May 21, 2018
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (Arcturus or the Company) (ARCT), an RNA medicines company, today announced that it will ...
May 21, 2018
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
NEW YORK, May 21, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (ATXI) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, ...
May 21, 2018
Arrowhead Pharmaceuticals Presents New Preclinical Data on ARO-ENaC for Treatment of Cystic Fibrosis
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (ARWR) today announced the presentation of new preclinical data on ARO-ENaC, formerly referred to as ARO-Lung1, for the treatment of ...
May 21, 2018
Arena Pharmaceuticals Announces Data Presentation for Ralinepag in Pulmonary Arterial Hypertension at the American Thoracic Society International Conference
SAN DIEGO, May 21, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that data from a post-hoc analysis of the 22-week Phase 2 clinical study for ...
May 21, 2018
CytoSorbents to Present at the 19th Annual B. Riley FBR Investor Conference
MONMOUTH JUNCTION, N.J., May 21, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation ...
May 16, 2018
ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections
RAMSEY, N.J. and BOCA RATON, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”) today announced that the United ...
May 16, 2018
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
REDWOOD CITY, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
May 16, 2018
PolarityTE Announces Rich Haerle as the New Vice President of Investor Relations and Corporate Strategy
SALT LAKE CITY, May 16, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL) today announced the appointment of Rich Haerle as Vice President of Investor Relations ...
May 16, 2018
Progeria Research Foundation Announces Collaboration and Supply Agreement with Eiger BioPharmaceuticals
PEABODY, Mass., May 16, 2018 /PRNewswire/ -- The Progeria Research Foundation (PRF) announced a collaboration and supply agreement with Eiger BioPharmaceuticals for the development and pursuit ...
May 16, 2018
Eiger Announces Expanded License Agreement with Merck for Investigational Candidate Lonafarnib and Collaboration with The Progeria Research Foundation (PRF)
PALO ALTO, Calif., May 16, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
May 16, 2018
BioLife Solutions Makes Investment in SAVSU Technologies to Support Growth and Capture Additional Regenerative Medicine Cold Chain Opportunities
BOTHELL, Wash., May 16, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical-grade biopreservation media, ("BioLife" or the "Company"), ...
May 16, 2018
Bellerophon to Present Positive Results from Phase 2 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease at the American Thoracic Society 114th International Conference
WARREN, N.J., May 16, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it will present ...
May 16, 2018
Albireo Enrolls First Patient in Phase 3 PFIC Trial of A4250
BOSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
May 16, 2018
Zealand Pharma - Interim report for the first quarter of 2018
Copenhagen, May 16, 2018 - Zealand Pharma A/S ("Zealand") (Company reg. No. 20 04 50 78), the Copenhagen-based company focused on discovery, design and development ...
May 16, 2018
Onxeo Provides Business Update and Reports First Quarter 2018 Financial Information
PARIS--(BUSINESS WIRE)--Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a biotechnology company specializing in the development of innovative drugs in oncology, notably against rare or ...
May 16, 2018
TherapeuticsMD Announces Investor and Analyst Day on June 4
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced that the Company will host an Investor and Analyst Day on Monday, ...
May 16, 2018
Molecular Templates to Present Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018
AUSTIN, Texas, May 16, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered ...
May 15, 2018
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018
CRANBURY, N.J., May 15, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of ...
May 15, 2018
BioCanCell Reports First Quarter 2018 Financial and Operational Results and Provides Corporate Update
CAMBRIDGE, Mass., May 15, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (BICL.TA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies ...
Page 40 of 117